Workflow
Luoniushan (000735)
icon
Search documents
罗 牛 山(000735) - 关于公司涉税事项的进展公告(二)
2026-03-27 11:31
证券代码:000735 证券简称:罗牛山 公告编号:2026-008 罗牛山股份有限公司 关于公司涉税事项的进展公告(二) 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 一、基本情况 罗牛山股份有限公司(以下简称"公司")分别于 2026 年 1 月 10 日披露了《关于公司涉税事项的公告》(公告编号:2026-002)和 2026 年 2 月 04 日披露了《关于公司涉税事项的进展公告》(公告编 号:2026-004)。 二、进展情况 鉴于公司涉税事项背景具有特殊性与复杂性,公司持续与相关行 政机关保持积极沟通。为更好地解决相关事项,经与税务机关充分协 商,由公司申请,国家税务总局海口市税务局决定终止行政复议;同 时,双方对前期相关税务文书的后续处理作出程序性安排,后续将根 据补充提供的证据情况再视情形作出相应税务处理。 三、风险提示 1、本次公司申请终止行政复议,并不代表公司放弃对该涉税事 项的持续推动及公司合法权益的维护,公司将进一步加强与相关行政 机关的沟通,争取妥善处理该事项。 4、请广大投资者谨慎决策,注意投资风险。 特此公告。 罗牛山股份有限公 ...
罗 牛 山(000735) - 关于收到海南证监局行政监管措施决定书的公告
2026-03-20 11:16
经查,罗牛山知悉相关涉税事项及进展后未及时履行信息披露义 务,违反了《上市公司信息披露管理办法》(证监会令第 182 号)第三 条第一款、第二十二条第一款、《上市公司信息披露管理办法》(证监 会令第 226 号)第三条第一款、第二十三条第一款的规定。徐自力作 为公司董事长、总裁,张慧作为公司董事会秘书,未按照《上市公司 信息披露管理办法》(证监会令第 182 号)第四条、第五十一条第二款、 《上市公司信息披露管理办法》(证监会令第 226 号)第四条、第五十 二条第二款的规定履行勤勉尽责义务,对公司上述违规行为负有主要 责任。 证券代码:000735 证券简称:罗牛山 公告编号:2026-007 罗牛山股份有限公司 关于收到海南证监局行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 罗牛山股份有限公司(以下简称"罗牛山"或"公司")及相关 人员于 2026 年 3 月 20 日收到中国证券监督管理委员会海南监管局 (以下简称"海南证监局")出具《关于对罗牛山股份有限公司、徐 自力、张慧采取出具警示函措施的决定》(〔2026〕10 号)( ...
罗 牛 山(000735) - 2026年2月畜牧行业销售简报
2026-03-09 08:00
罗牛山股份有限公司 2026 年 2 月畜牧行业销售简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没 有虚假记载、误导性陈述或重大遗漏。 一、2026 年 2 月份生猪销售情况 公司 2026 年 2 月销售生猪 4.82 万头,环比下降 18.53%,同比下降 1.95%;销售收入 8,022.06 万元,环比下降 22.24%,同比下降 20.34%。 2026 年 1-2 月,公司累计销售生猪 10.73 万头,同比增长 21.43%; 累计销售收入 18,338.09 万元,同比增长 0.09%。 上述数据未经审计,与定期报告披露的数据可能存在差异,因此上述 数据仅作为阶段性数据供投资者参考。 二、风险提示 (一)上述披露仅包含公司生猪养殖业务销售情况,不含其它业务。 (二)生猪市场价格的大幅波动(下降或上升),都可能会对公司的 经营业绩产生重大影响,敬请广大投资者审慎决策,注意投资风险。 证券代码:000735 证券简称:罗牛山 公告编号:2026-006 (三)生猪市场价格变动的风险是整个生猪生产行业的系统风险,对 任何一家生猪生产者来说,都是客观存在的、不可控制的外部风险。 三 ...
罗牛山(000735.SZ):没有开展且没有筹划“赛马项目”的工作安排
Ge Long Hui· 2026-02-26 08:36
Core Viewpoint - The company, Roniu Mountain (000735.SZ), has stated that it is currently not engaged in or planning any "horse racing projects" [1] Group 1 - The company confirmed through its interactive platform that there are no ongoing or planned activities related to horse racing projects [1]
罗牛山:目前公司开发、在售的房地产项目为“玖悦台”及“璞域”
Zheng Quan Ri Bao· 2026-02-24 11:37
(文章来源:证券日报) 证券日报网讯 2月24日,罗牛山在互动平台回答投资者提问时表示,目前公司开发、在售的房地产项目 为"玖悦台"及"璞域"。各项目的交付标准以销售现场公示的《商品房买卖合同》约定内容为准,相关信 息已在售楼处依法依规进行公示。关于不同户型、楼栋的具体交付标准(毛坯或精装)属于销售层面的 具体业务信息,如有购房需求,敬请关注公司在售楼处的官方公示信息。 ...
罗牛山:截至2026年2月13日公司股东总户数约为11.49万户
Zheng Quan Ri Bao Wang· 2026-02-24 10:10
证券日报网讯2月24日,罗牛山(000735)在互动平台回答投资者提问时表示,截至2026年2月13日,公 司股东总户数约为11.49万户。 ...
罗牛山与嘉吉签署战略合作,生猪销售增长股价震荡
Jing Ji Guan Cha Wang· 2026-02-15 01:27
Group 1 - The core viewpoint of the articles highlights recent business developments and operational data of the company, Luo Niu Shan, including a strategic partnership with Cargill and significant sales growth in January 2026 [1] - On February 4, Luo Niu Shan signed a strategic cooperation agreement with Cargill for the year 2026, focusing on stabilizing soybean meal supply and optimizing costs, as well as establishing a price risk control system in Hainan [1] - The company reported a notable performance in January 2026, with pig sales reaching 59,100 heads, a year-on-year increase of 50.72%, and sales revenue of 103 million yuan, up 25.03%, indicating short-term improvements in supply [1] Group 2 - The stock price of Luo Niu Shan has shown a downward trend recently, closing at 7.64 yuan on February 13, with a slight increase of 0.53% on that day, but a cumulative decline of 1.29% over the past five days [2] - During the week of February 2 to 6, the stock price dropped by 8.40%, with a net outflow of 153 million yuan in principal funds, reflecting market pressure [2] - On the latest trading day (February 13), there was a net inflow of 18.79 million yuan in principal funds, although the overall industry, particularly the breeding sector, experienced a decline of 0.46% during the same period [2]
罗牛山:2026年1月销售生猪5.91万头 销售收入10316.03万元
Jin Rong Jie· 2026-02-09 12:59
Group 1 - The core point of the article is that the company, 罗牛山, reported an increase in pig sales and revenue for January 2026, indicating strong demand due to the upcoming Spring Festival [1] - The company sold 59,100 pigs in January 2026, representing a month-on-month increase of 0.93% and a year-on-year increase of 50.72% [1] - The sales revenue for January 2026 was 103.16 million yuan, showing a month-on-month growth of 3.55% and a year-on-year growth of 25.03% [1] Group 2 - The increase in pig sales is attributed to heightened customer demand as the Spring Festival approaches and an increase in the number of market-ready pigs [1] - The disclosed data only includes sales from the pig farming business and does not account for other business operations [1] - The company cautions that significant fluctuations in the pig market prices could have a major impact on its operational performance [1]
A股三家养殖公司发布1月业绩:销售收入同比实现正增长
Zhong Guo Xin Wen Wang· 2026-02-09 12:26
Group 1 - The core viewpoint of the article highlights that three Chinese A-share breeding companies reported positive year-on-year sales growth for January, with the highest increase exceeding 25% [1] Group 2 - Company Luoniushan reported sales of 59,100 pigs in January 2026, with a month-on-month increase of 0.93% and a year-on-year increase of 50.72%. The sales revenue was approximately 103 million yuan, reflecting a month-on-month growth of 3.55% and a year-on-year growth of 25.03% [1] - The increase in sales volume for Luoniushan was attributed to heightened customer demand ahead of the Spring Festival and an increase in the number of market pigs sold [1] Group 3 - Company Zhengbang Technology reported sales of 927,500 pigs in January 2026, including 530,500 piglets and 397,000 market pigs, marking a year-on-year increase of 62.33%. The sales revenue reached 816 million yuan, up 19.69% year-on-year [1] - The significant year-on-year increase in sales volume for Zhengbang Technology was primarily due to the gradual recovery of the company's business [1] Group 4 - Company Xiangjia announced sales of 4.0327 million live poultry in January, with sales revenue of approximately 9.03498 million yuan, representing year-on-year growth of 1.15% and 10.42%, respectively [1]
2月9日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-09 10:13
Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]